Total Payments
$4,760
2024 Payments
$663.32
Companies
39
Transactions
223
Medicare Patients
3,946
Medicare Billing
$342,535
Payment Breakdown by Category
Food & Beverage$4,705 (98.8%)
Education$54.95 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,705 | 222 | 98.8% |
| Education | $54.95 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $624.63 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $498.53 | 17 | $0 (2024) |
| Optinose US, Inc. | $455.55 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $442.50 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $436.85 | 25 | $0 (2024) |
| Acclarent, Inc | $256.81 | 13 | $0 (2021) |
| ABBVIE INC. | $210.77 | 10 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $190.79 | 8 | $0 (2022) |
| Stryker Corporation | $190.34 | 5 | $0 (2024) |
| Hill Dermaceuticals, Inc. | $137.85 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $663.32 | 32 | Regeneron Healthcare Solutions, Inc. ($155.70) |
| 2023 | $921.00 | 37 | Regeneron Healthcare Solutions, Inc. ($234.82) |
| 2022 | $926.19 | 49 | GENZYME CORPORATION ($145.11) |
| 2021 | $732.15 | 37 | GENZYME CORPORATION ($143.81) |
| 2020 | $566.02 | 22 | Hill Dermaceuticals, Inc. ($137.85) |
| 2019 | $455.88 | 17 | AstraZeneca Pharmaceuticals LP ($137.69) |
| 2018 | $286.53 | 16 | Stryker Corporation ($41.37) |
| 2017 | $208.49 | 13 | Entellus Medical, Inc. ($61.39) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2024 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: INSTRUMENTS | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Immunology | ||||||
| 07/09/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Immunology | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,148 | 2,673 | $209,893 | $87,712 |
| 2022 | 19 | 916 | 2,136 | $203,973 | $81,935 |
| 2021 | 21 | 1,005 | 2,627 | $225,111 | $98,859 |
| 2020 | 20 | 877 | 2,276 | $194,351 | $74,029 |
Total Patients
3,946
Total Services
9,712
Medicare Billing
$342,535
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 396 | $69,300 | $35,235 | 50.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $27,936 | $11,184 | 40.0% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2023 | 69 | 76 | $14,060 | $6,107 | 43.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 128 | 153 | $12,400 | $5,163 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 36 | $9,144 | $4,992 | 54.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 27 | 33 | $10,098 | $4,302 | 42.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 11 | 340 | $6,800 | $3,393 | 49.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 113 | 274 | $9,864 | $2,713 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 42 | $7,350 | $2,615 | 35.6% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 39 | 39 | $7,020 | $2,267 | 32.3% |
| 69200 | Removal of foreign body in ear canal | Office | 2023 | 17 | 26 | $7,875 | $1,830 | 23.2% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 17 | 17 | $5,899 | $1,709 | 29.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,472 | $1,569 | 28.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 29 | 39 | $3,900 | $1,441 | 36.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 104 | 288 | $3,456 | $1,356 | 39.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 29 | 33 | $6,600 | $1,108 | 16.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $1,008 | $454.16 | 45.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 98 | 588 | $1,176 | $212.32 | 18.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 39 | 65 | $325.00 | $53.47 | 16.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 84 | $210.00 | $7.36 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 404 | $70,700 | $35,465 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 110 | 110 | $31,680 | $11,142 | 35.2% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 13 | 29 | $24,200 | $8,617 | 35.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 33 | 44 | $13,464 | $5,625 | 41.8% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2022 | 46 | 54 | $9,990 | $4,598 | 46.0% |
About Dr. Michael Hickham, MD
Dr. Michael Hickham, MD is a Specialist healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518967793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hickham, MD has received a total of $4,760 in payments from pharmaceutical and medical device companies, with $663.32 received in 2024. These payments were reported across 223 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,705).
As a Medicare-enrolled provider, Hickham has provided services to 3,946 Medicare beneficiaries, totaling 9,712 services with total Medicare billing of $342,535. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Otolaryngology
- Location Metairie, LA
- Active Since 07/28/2005
- Last Updated 06/08/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518967793
Products in Payments
- DUPIXENT (Biological) $1,164
- Xhance (Drug) $455.55
- NUCALA (Biological) $339.55
- SUNOSI (Drug) $190.79
- QULIPTA (Drug) $139.85
- DermOtic (Drug) $137.85
- Inspire Upper Airway Stimulation System (Device) $129.40
- NURTEC ODT (Drug) $129.26
- Ryaltris (Drug) $124.09
- SCOPIS ENT (Device) $112.06
- SYMBICORT (Drug) $106.70
- FASENRA (Drug) $97.19
- SINUVA (Drug) $88.43
- TRELEGY ELLIPTA (Drug) $76.80
- ACCLARENT NAVWIRE Sinus Navigation Guidewire (Device) $75.71
- UBRELVY (Drug) $70.92
- DSUVIA (Drug) $67.10
- XprESS Multi-Sinus Dilation System (Device) $61.39
- Odactra (Drug) $59.49
- AIRSUPRA (Drug) $53.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Metairie
Dr. Patricia Farris, M.d, M.D
Specialist — Payments: $121,914
Specialist $121,914
Kamran Khoobehi, Md, MD
Specialist — Payments: $30,616
Specialist $30,616
Dr. Barbara Bopp, M.d, M.D
Specialist — Payments: $30,385
Specialist $30,385
Dr. Joseph Uddo, M.d, M.D
Specialist — Payments: $18,816
Specialist $18,816
Dr. James Rooney, M.d, M.D
Specialist — Payments: $18,407
Specialist $18,407
Dr. Felix Bopp, M.d, M.D
Specialist — Payments: $17,391
Specialist $17,391